Kwan Goo Edmond (Ed) Cho has been appointed president of Harlan Korea. Mr. Cho will have full profit and loss responsibility and overall accountability for the Harlan Contract Research Services (CRS) business serving the Korean chemical, agrochemical and pharmaceutical markets.   Prior to joining the company, Mr. Cho was director of market access and business development for Zuellig Pharma Korea, which provides contract services and clinical reach to multinational companies in more than 15 count...